Disparities in Asthma Medication Dispensing Patterns: The Case of Pediatric Asthma in Puerto Rico

University of Puerto Rico, Medical Sciences Campus, Behavioral Sciences Research Institute, Puerto Rico.
Journal of Asthma (Impact Factor: 1.8). 11/2010; 47(10):1136-41. DOI: 10.3109/02770903.2010.517338
Source: PubMed


Disparities exist in asthma medication dispensing between children with public insurance and those with private insurance under a Managed Care Medicaid system in Puerto Rico.
Island-wide medical claims data were used to examine the extent to which differences between the private and public health care sectors affect medication dispensing and health care utilization among asthmatic children.
Children 3-18 years old with at least one service claim [outpatient, hospitalization, or emergency department (ED) visit] for asthma or reactive airway disease from 2005 to 2006 were selected. Chi-square analyses compared medication dispensing and health care utilization between the public and private sectors. Negative binomial regression identified factors associated with the mean dispensing rate of prescriptions for anti-inflammatory controller medication (CM).
Private insurance families (n = 28,088) were dispensed significantly more CM (48.3% vs. 12.0%) and quick relief medication (47.4% vs. 44.6%) than public insurance families (n = 13,220). The dispensing of inhaled corticosteroids (24.4% vs. 6.7%) and leukotriene modifiers and cromolyn (31.4% vs. 5.7%) was dramatically higher in the private sector. In contrast, emergency room use was significantly higher among public insurance children (51.7% vs. 13.8%). Multivariate analysis showed that age, number of β-agonists, and type of insurance was associated with CM dispensing; private insurance showed the greatest effect.
Asthmatic Puerto Rican children enrolled in public insurance were significantly less likely to be dispensed CM than children with private insurance; suggesting that under-treatment of public insured children may substantially contribute to increased asthma morbidity in this population as evidenced by significantly higher rates of ED visits.
A disparity exists in asthma medication dispensing between children with public insurance compared with those with private insurance under a Managed Care Medicaid system in Puerto Rico. If asthma disparities in medication dispensing are to be reduced, then a better understanding of the complex ways in which multiple variables related to the health care system policies, socioeconomic factors, family and provider interactions, as well as the relative weight that each one contributes to the observed inequalities is needed.

Download full-text


Available from: Glorisa Canino
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: There are substantial disparities in dispensing patterns of long term control medications for asthma among children in Puerto Rico with public insurance as compared to those with private insurance. Public health insurance policy in Puerto Rico includes the cost of medications in the capitation paid to the primary care physicians and clinics. METHODS: Survey questionnaires were mailed to all pediatricians enrolled in the Puerto Rico College of Physicians (n=798) in addition to some pediatricians not enrolled in the College (n=25) for a total of 823 pediatricians. Of these, 722 were eligible pediatricians with 458 responding to the survey for a response rate of 63.4%. RESULTS: Most of the respondents expressed being moderately to very familiar with the National Asthma Education and Prevention Program (NAEPP) guidelines (71.7%) and with the NAEPP recommendations for controller asthma medication use (73.5%). Inadequate capitation to cover asthma medication (86.2%) and lack of adequate health insurance coverage of the patient (83.2%) however, were the most frequent barriers reported by pediatricians for prescribing controller asthma medication to children with public health insurance. The most frequent strategies used to provide controller asthma medication to these children were prescription of oral medications (59.5%) and giving away samples (44.7%). CONCLUSIONS: Current public health insurance policy in Puerto Rico creates a disincentive to the appropriate prescription of long term control medication for children with asthma. To improve the quality of asthma care of children in Puerto Rico, revision of this public health insurance policy is necessary.
    Full-text · Article · Nov 2010
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Puerto Rican children maintain disproportionately high asthma prevalence rates and effective asthma management interventions are needed. This article describes how community-based participatory research (CBPR) was implemented in the development of a culturally tailored family asthma management intervention for Puerto Rican children: CALMA (a Spanish acronym for Take Control, Empower Yourself, and Achieve Asthma Management). CALMA was developed according to CBPR principles and contemporary asthma guidelines through the collaboration of diverse members of the local, professional, and medical communities, academia, and local government. All group members contributed unique perspectives, making CALMA's development a collaborative effort. The CALMA community dealt with challenges in both incorporating and managing a diverse group of stakeholders and maintaining equity in decision making power. However, the community maintained strengths, such as incorporating culturally accepted remedies and addressing culturally specific myths in the intervention, as well as having the medical community directly involved in overseeing the accuracy of the intervention. A CBPR approach enhanced the cultural sensitivity of the intervention as well as its potential for sustainability.
    Full-text · Article · Dec 2010 · Progress in community health partnerships: research, education, and action
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives To explore the association between the type of prescription drug plan (PDP) and taking preventive daily asthma medication (controller medication) in patients with poor asthma control of their asthma (defined as taking more than three canisters of short-acting β-agonists each month). Methods A retrospective, cross-sectional study using the 2008 Medical Expenditure Panel Survey, a nationally representative sample of the non-institutionalized, civilian US population. Asthma patients were identified by International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code 493. Only those patients that reported use of more than three canisters of rescue inhalers in a 3-month period were included. Based on patients' self-reported use of preventive medications, they were classified as controller drug users and non-users. Descriptive statistics were used to describe the population. A multiple logistic regression model was used to determine odds of controller usage based on type of PDP using demographic characteristics (age, gender, race, ethnicity, income, perceived health status) as confounders. All analysis was done using SAS version 9.1. Key findings Asthma controller drug use was found to be 67% among the study population. The logistic regression analysis showed that patients having Medicare as their PDP were more likely to use controller medications compared with patients with no PDP (odds ratio (OR) 4.58, 95% confidence interval (CI) 1.33–15.77). Higher odds were seen for Medicaid (OR 2.09, CI 0.96–4.54) and Veterans Affairs (OR 1.66, CI 0.16–17.05) prescription beneficiaries too, but the effect was not significant. Conclusions Type of PDP was found to have an effect of utilization of controller drugs among asthma patients. Future research should explore viable plan options that encourage guideline-recommended medication use in asthma patients.
    Full-text · Article · Jan 2011 · Journal of Pharmaceutical Health Services Research
Show more